Huge PE, VC biotech deal value slump in July masks consistent underlying...
Private equity and venture capital investment activity in the biotech sector was suppressed by a lack of $200m-plus deal in July, new research shows.
View ArticleGlobal private equity dealmaking soars to second highest value of last 12...
Global private equity dealmaking continued its strong 2017 by hitting the second-highest value total of the past 12 months, new research has shows.
View ArticlePE fundraising boom approaching 2007 pre-crisis peak as megafunds dominate...
Private equity's booming fundraising market is on course for another record year to bring it ever-closer to trumping the heady pre-crisis peak of 2007, new research shows.
View ArticlePE, VC investment in cleantech scores strong start to summer despite slowdown
Private equity and venture capital investment in cleantech scored a stronger result going into this year's summer slowdown than in 2016, but still fared poorly in monthly terms, new research shows.
View ArticleCEE fundraising spiked faster than wider Europe last year thanks to funds of...
Private equity fundraising in the Central and Eastern European region soared 62 per cent cent last year to outpace even the hectic rise in capital raising being experienced across the wider continent,...
View ArticleDeveloped markets outside US outperform public markets, but emerging markets...
Private equity and venture capital managers in developed markets outside the US outperformed their comparable public markets last year - but the news was less good for emerging markets, new research...
View ArticleSurprise summer PE dealmaking highs come to and end with September slump
Global private equity deal value drooped to its lowest result in eight months in September to mark the end of a surprisingly strong summer dealmaking period this year.
View ArticleCleantech sees weakest PE, VC monthly investment total of the year following...
Private equity and venture capital investment in the cleantech sector fell back to one of its lowest levels of the last 12 months in September following a mammoth August result, new research shows.
View ArticleBiotech industry sees strong September for PE, VC investment despite...
Private equity and venture capital investments in the biotech industry dropped in September, despite the overall value of deals scoring one of its best results of the past 12 months.
View ArticlePE, VC outside US underperforming public markets in the short term
Private equity and venture capital managers in developed markets outside the US underperformed comparable public market indices in the first quarter of this year, new research suggests.
View ArticleGlobal buyout dealmaking suffers second slow month, value still up year-on-year
Global private equity deal value and volume continued a second month of slow results in October, following six months of consistently strong numbers, new research shows.
View ArticleCleantech investment slump from PE, VC funds continues, value down 70 per...
The total value of monthly private equity and venture capital dealmaking in the cleantech industry continued to weaken in October, dropping almost 50 per cent month-on-month according to new research...
View ArticleFewer, bigger deals leading European private equity exit activity surge
The European private equity industry has seen a surge in exit activity in 2017 to date thanks to a string of large deals, new research shows.
View ArticleBiotech industry sees strong PE, VC deal activity as end of year looms
The global biotech industry is recording a strong finish to the year in terms of private equity investment, despite a dropoff in capital from October's highs.
View ArticleCleantech PE, VC investment recovers after two-month slump
Private equity and venture capital investing in cleantech is back on the rise after a brief slump in the wake of a bumper August, new research suggests.
View ArticleRising limited partner ESG demands driving change at private equity managers
Increasing LP demand for private equity firms to consider environmental, social and governance factors when making investment decisions is boosting GP integration of ESG in their day-to-day business,...
View ArticlePE records biggest dealmaking value total for a decade in 2017 despite...
Overall private equity dealmaking value rebounded to a ten-year high across 2017 despite volume sliding for the second consecutive year, new research reveals.
View ArticleBiotech breaks annual deal value record in 2017 with $15.4bn of transactions
The value of global private equity and venture capital investment in biotech companies rocketed last year to a record $15.4bn of announced deals, new research shows.
View ArticlePrivate equity seals flying start to 2018 with second-highest deal value...
Private equity investment got off to a flying start in 2018 by striking $68.8bn of deal value, the second-highest value recorded for the last 12 months.
View ArticlePromising PE, VC cleantech investment rise suffers hiccup at start of 2018
A promising uptick in private equity and venture capital investment in the cleantech industry fell back in January thanks to a lack of large deals, new research shows.
View Article
